Search research articles
Contact Us
Filters
Showing results (21-30 of 269) with videos related to
Page
of 27
Sort By:
Journal of Crohn'S & Colitis
|
November 10, 2021
A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease
Geert D'Haens, Silvio Danese, Martin Davies, et al.
Journal of Crohn'S & Colitis
|
January 7, 2021
Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index
Steven Bots, Kim Nylund, Mark Löwenberg, et al.
Journal of Patient-Reported Outcomes
|
October 9, 2018
Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
Mary Kaye Willian, Geert D'Haens, Aaron Yarlas, et al.
The American Journal of Gastroenterology
|
May 9, 2012
Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis
Geert D'Haens, William J Sandborn, Karen Barrett, et al.
Inflammatory Bowel Diseases
|
August 18, 2009
Clinical guidelines for the management of pouchitis
Darrell S Pardi, Geert D'Haens, Bo Shen, et al.
Current Gastroenterology Reports
|
November 12, 2009
Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease)
Marc Ferrante, Geert D'Haens, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
August 13, 2019
Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
Jean-Frédéric Colombel, Geert D'haens, Wan-Ju Lee, et al.
Drugs
|
November 12, 2024
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, et al.
Journal of Crohn'S & Colitis
|
April 3, 2012
What do changes in inflammatory bowel disease management mean for our patients?
Subrata Ghosh, Geert D'Haens, Brian G Feagan, et al.
Acta Gastro-Enterologica Belgica
|
July 11, 2007
Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study
Eduard Louis, Jacques Boverie, Olivier Dewit, et al.
Page
of 27
Search research articles
Search
Showing results (21-30 of 269) with videos related to
Sort By:
Page
of 27
Journal of Crohn'S & Colitis
|
November 10, 2021
A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease
Geert D'Haens, Silvio Danese, Martin Davies, et al.
Journal of Crohn'S & Colitis
|
January 7, 2021
Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index
Steven Bots, Kim Nylund, Mark Löwenberg, et al.
Journal of Patient-Reported Outcomes
|
October 9, 2018
Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study
Mary Kaye Willian, Geert D'Haens, Aaron Yarlas, et al.
The American Journal of Gastroenterology
|
May 9, 2012
Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis
Geert D'Haens, William J Sandborn, Karen Barrett, et al.
Inflammatory Bowel Diseases
|
August 18, 2009
Clinical guidelines for the management of pouchitis
Darrell S Pardi, Geert D'Haens, Bo Shen, et al.
Current Gastroenterology Reports
|
November 12, 2009
Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease)
Marc Ferrante, Geert D'Haens, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
August 13, 2019
Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review
Jean-Frédéric Colombel, Geert D'haens, Wan-Ju Lee, et al.
Drugs
|
November 12, 2024
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Andrew Ainsworth, et al.
Journal of Crohn'S & Colitis
|
April 3, 2012
What do changes in inflammatory bowel disease management mean for our patients?
Subrata Ghosh, Geert D'Haens, Brian G Feagan, et al.
Acta Gastro-Enterologica Belgica
|
July 11, 2007
Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study
Eduard Louis, Jacques Boverie, Olivier Dewit, et al.
Page
of 27